AdaptHealth (AHCO) Change in Receivables (2019 - 2026)
AdaptHealth's (AHCO) quarterly Change in Receivables came in at $21.1 million in Q1 2026, up 36.55% year-on-year from $15.4 million in Q1 2025, and up 338.23% quarter-over-quarter from -$8.8 million in Q4 2025.
AdaptHealth (AHCO) Change in Receivables (2019 - 2026) Analysis & Trends
AdaptHealth's Change in Receivables history runs 8 years deep, the most recent figure standing at $21.1 million for Q1 2026.
- On a quarterly basis, Change in Receivables rose 36.55% year-over-year to $21.1 million in Q1 2026; TTM through Mar 2026 was -$25.3 million, a 2637.14% decrease from a year earlier, with the FY2025 full-year figure at -$31.0 million, down 218.19% from the prior year.
- Change in Receivables climbed to $21.1 million in Q1 2026 per AHCO's latest filing, from -$8.8 million in the prior quarter.
- Across five years, Change in Receivables topped out at $40.6 million in Q1 2024 and bottomed at -$35.9 million in Q3 2024.
- The 5-year median for Change in Receivables is $5.0 million (2023), against an average of $2.7 million.
- Biggest YoY gain for Change in Receivables was 786.6% in 2024; the steepest drop was 812.66% in 2024.
- Year by year, Change in Receivables stood at $2.6 million in 2022, then soared by 633.4% to $18.8 million in 2023, then declined by 26.07% to $13.9 million in 2024, then slumped by 163.57% to -$8.8 million in 2025, then soared by 338.23% to $21.1 million in 2026.
- Per Business Quant, the three latest AHCO Change in Receivables figures stand at $21.1 million (Q1 2026), -$8.8 million (Q4 2025), and -$13.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | AdaptHealth | 1.42 Bn | 1.38 Bn | 111.50 Mn | 21.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.07 Mn |
| Mar 31, 2026 | 21.07 Mn |
| Dec 31, 2025 | -8.84 Mn |
| Dec 31, 2025 | -8.84 Mn |
| Sep 30, 2025 | -13.27 Mn |
| Sep 30, 2025 | -13.27 Mn |
| Jun 30, 2025 | -24.30 Mn |
| Jun 30, 2025 | -24.30 Mn |
| Mar 31, 2025 | 15.43 Mn |
| Mar 31, 2025 | 15.43 Mn |
| Dec 31, 2024 | 13.91 Mn |
| Dec 31, 2024 | 13.91 Mn |
| Sep 30, 2024 | -35.86 Mn |
| Sep 30, 2024 | -35.86 Mn |
| Jun 30, 2024 | 7.52 Mn |
| Jun 30, 2024 | 7.52 Mn |
| Mar 31, 2024 | 40.65 Mn |
| Mar 31, 2024 | 40.65 Mn |
| Dec 31, 2023 | 18.82 Mn |
| Dec 31, 2023 | 18.82 Mn |